Showing results (311-320 of 1,962) with videos related to
Sort By:
Pageof 197
Expert Opinion on Drug Discovery|July 9, 2013
Advances in MRSA drug discovery: where are we and where do we need to be?Michio Kurosu, Shajila Siricilla, Katsuhiko MitachiExpert Opinion on Drug Discovery|July 20, 2013
Predictive approaches to increase absorption of compounds during lead optimisationKlara Valko, James Butler, Peter EddershawExpert Opinion on Drug Discovery|March 20, 2013
Carvedilol case history: the discovery and development of the first β-blocker for the treatment of congestive heart failureRobert R Ruffolo, Giora Z FeuersteinExpert Opinion on Drug Discovery|March 20, 2013
10th annual drug discovery technology(®) europe and infotechpharma(®) conferenceShabana Kiyani, Emma Quigley, Amy Schlachter, et al.Expert Opinion on Drug Discovery|March 20, 2013
In situ click chemistry: a powerful means for lead discoveryK Barry Sharpless, Roman ManetschExpert Opinion on Drug Discovery|March 20, 2013
Entering the era of proteomics in rheumatologyStijn Lambrecht, Dieter Deforce, Dirk ElewautExpert Opinion on Drug Discovery|March 20, 2013
Functional interrogation of breast cancer: from models to drugsSharon F McGee, Darran P O'Connor, William M GallagherExpert Opinion on Drug Discovery|March 20, 2013
An update on hybrid drugs in cardiovascular drug researchVincenzo CalderoneExpert Opinion on Drug Discovery|March 20, 2013
Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibitionAc Backes, B Zech, B Felber, et al.Expert Opinion on Drug Discovery|March 20, 2013
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibitionAc Backes, B Zech, B Felber, et al.Pageof 197